🔎 Trials Near Me

Domov › Debelost › Nevada › Las Vegas

Klinične študije za Debelost v Las Vegas, NV

27 študij za Debelost išče udeležence na lokacijah v Las Vegas in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 2
  • Vector Clinical Trials /ID# 282265, Las Vegas
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Vključevanje udeležencevFaza 2
  • Excel Clinical Research, LLC, Las Vegas
  • Palm Research Center Tenaya, Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Vključevanje udeležencevFaza 3
  • Palm Research Center Inc., Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07720271

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Palm Research Center Tenaya, Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Vključevanje udeležencevFaza 3
  • Excel Clinical Research, Las Vegas
  • Vector Clinical Trials, Las Vegas
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • AMR Clinical, Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • Las Vegas Medical Research, Las Vegas
Starost 18–75 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 3
  • AURORA-1 Clinical Site, Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • AURORA-2 Clinical Site, Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
  • ACCOMPLISH-2 Research Site, Las Vegas
Starost 18–79 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Vključevanje udeležencevFaza 3
  • Jubilee Clinical Research, Inc., Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • Las Vegas Medical Research, Las Vegas
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Vector Clinical Trials, Las Vegas
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07215559

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Vključevanje udeležencevFaza 3
  • Kailera Clinical Site, Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Vključevanje udeležencevFaza 3
  • Palm Research Center Inc, Las Vegas
  • Vector Clinical Trials, Las Vegas
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Vključevanje udeležencevFaza 3
  • Kailera Clinical Site, Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Vključevanje udeležencevFaza 3
  • Palm Research Center Inc, Las Vegas
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Vključevanje udeležencevFaza 3
  • Kailera Clinical Site, Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07284979

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Vključevanje udeležencevFaza 3
  • Excel Clinical Research, Las Vegas
Starost 18–99 · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07575399

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • University of Nevada, Las Vegas, Las Vegas
Starost 21–74 · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Vključevanje udeležencevFaza 3
  • UMC of Southern Nevada, Las Vegas
  • Palm Research Center Inc-Vegas, Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Vključevanje udeležencevFaza 3
  • ACCOMPLISH-1 Research Site, Las Vegas
Starost 18–79 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07654361

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Vključevanje udeležencevFaza 2
  • Palm Research Center, Mountainview Medical Center, Las Vegas
Starost 18–80 · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT07477704

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Vključevanje udeležencevFaza 3
  • Jubilee Clinical Research, Inc., Las Vegas
Starost 18 in več · Vsi spoli · Posodobljeno 9. jul. 2026 · NCT07481630

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

Vključevanje udeležencevFaza 1
  • Corxel Investigational site, Las Vegas
Starost 18–55 · Ženske · Posodobljeno 17. jun. 2026 · NCT07652047

Študije za Debelost v drugih mestih

Druge študije v Las Vegas

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.